"Induction chemotherapy and ablative 5-fraction stereotactic magnetic resonance guided adaptive radiation therapy for patients with initially inoperable adenocarcinoma of the pancreas" by Michael Chuong

Presentation

Induction chemotherapy and ablative 5-fraction stereotactic magnetic resonance guided adaptive radiation therapy for patients with initially inoperable adenocarcinoma of the pancreas

All Publications

Michael Chuong, Miami Cancer Institute
Robert Herrera, Miami Cancer Institute
Muni Rubens, Miami Cancer Institute
Adeel Kaiser, Miami Cancer Institute
Rupesh Kotecha, Miami Cancer Institute
Matthew Hall, Miami Cancer Institute
James McCulloch, Miami Cancer Institute
Antonio Ucar, Miami Cancer Institute
Fernando De Zarraga, Miami Cancer Institute
Santiago Aparo, Miami Cancer Institute
Horacio Asbun, Miami Cancer Institute
Domenech Asbun, Miami Cancer Institute
Ramon Jimenez, Miami Cancer Institute
Govindarajan Narayanan, Miami Cardiac & Vascular Institute
Tino Romaguera, Miami Cancer Institute
Diane Alvarez, Miami Cancer Institute
Alonso Gutierrez, Miami Cancer Institute
Kathryn Mittauer, Miami Cancer Institute

Publication Date

6-19-2022

Presented At:

15th International Stereotactic Radiosurgery Society Congress

Content Type

Poster

Citation Information

Michael Chuong, Robert Herrera, Muni Rubens, Adeel Kaiser, et al.. "Induction chemotherapy and ablative 5-fraction stereotactic magnetic resonance guided adaptive radiation therapy for patients with initially inoperable adenocarcinoma of the pancreas" (2022)
Available at: http://works.bepress.com/adeel-kaiser/108/